Independent Reviews & Data

Compare diabetes technology without the marketing spin.

Detailed specifications, clinical trial data, and direct comparisons of continuous glucose monitors (CGMs) and automated insulin delivery systems.

Compare CGMs Compare Pumps

No sponsored reviews

Evidence-based data

Current Glucose

114 mg/dL

Time in Range (70-180) 82%

Active Insulin

1.2 U

Algorithm Status

Automated

Device Categories

Select a category to view detailed specifications and comparisons.

Continuous Glucose Monitors

Compare MARD (accuracy), wear time, warmup periods, and app integrations for Dexcom, Libre, and Eversense.

Insulin Pumps (AID)

Evaluate tubed and tubeless automated insulin delivery systems like Omnipod 5, Tandem t:slim X2, and Medtronic 780G.

Smart Insulin Pens

Connected pens like InPen that offer pump-like calculations (active insulin tracking, dose calculators) for MDI therapy.

Understanding Closed-Loop Systems

Automated Insulin Delivery (AID), or closed-loop systems, represent the current standard of care for Type 1 diabetes management. These systems combine three components:

Sensor (CGM)

Continuously measures interstitial glucose levels every 1-5 minutes and transmits data.
Algorithm

Software that predicts future glucose levels and determines required insulin adjustments.
Pump

The hardware that receives commands from the algorithm and automatically adjusts basal delivery.

Read the Full Guide

Clinical Outcomes (AID vs MDI)

Aggregate data from pivotal trials showing typical improvements when switching from Multiple Daily Injections (MDI) to Automated Insulin Delivery (AID).

Time in Range (70-180 mg/dL) +11 to 15%

MDI Baseline: ~58% AID Average: ~73%

HbA1c Reduction -0.3 to -0.5%

Time Below Range (<70 mg/dL) Reduced

Target: <4% AID Average: 1-2%

Source: Consensus Statement by the American Association of Clinical Endocrinology and American College of Endocrinology (2021).